BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28531167)

  • 1. A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?
    Schreiner S; Nassal M
    Viruses; 2017 May; 9(5):. PubMed ID: 28531167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Hepatitis B Virus cccDNA and Minichromosome Formation and HBV Gene Transcription.
    Gómez-Moreno A; Ploss A
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infection.
    Hofmann S; Luther J; Plank V; Oswald A; Mai J; Simons I; Miller J; Falcone V; Hansen-Palmus L; Hengel H; Nassal M; Protzer U; Schreiner S
    Microbiol Spectr; 2024 May; 12(5):e0378823. PubMed ID: 38567974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.
    Hofmann S; Plank V; Groitl P; Skvorc N; Hofmann K; Luther J; Ko C; Zimmerman P; Bruss V; Stadler D; Carpentier A; Rezk S; Nassal M; Protzer U; Schreiner S
    Microbiol Spectr; 2023 Jun; 11(3):e0044623. PubMed ID: 37199632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA.
    Zhuang AQ; Chen Y; Chen SM; Liu WC; Li Y; Zhang WJ; Wu YH
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants.
    Martinez MG; Combe E; Inchauspe A; Mangeot PE; Delberghe E; Chapus F; Neveu G; Alam A; Carter K; Testoni B; Zoulim F
    mBio; 2022 Apr; 13(2):e0288821. PubMed ID: 35389262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.
    Xia Y; Guo H
    Antiviral Res; 2020 Aug; 180():104824. PubMed ID: 32450266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis.
    McDaniel YZ; Patterson SE; Mansky LM
    Antiviral Res; 2019 Oct; 170():104540. PubMed ID: 31247245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Transcriptional Regulation of HBV Replication: RNA Quality Also Matters.
    Giraud G; El Achi K; Zoulim F; Testoni B
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus.
    Kostyushev D; Brezgin S; Kostyusheva A; Zarifyan D; Goptar I; Chulanov V
    Cell Mol Life Sci; 2019 May; 76(9):1779-1794. PubMed ID: 30673820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Hepatitis B Virus RNAs Are Heterogeneous in Length and Circulate as Capsid-Antibody Complexes in Addition to Virions in Chronic Hepatitis B Patients.
    Bai L; Zhang X; Kozlowski M; Li W; Wu M; Liu J; Chen L; Zhang J; Huang Y; Yuan Z
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30282709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolin binds to and regulates transcription of hepatitis B virus covalently closed circular DNA minichromosome.
    Xia Y; Cheng X; Nilsson T; Zhang M; Zhao G; Inuzuka T; Teng Y; Li Y; Anderson DE; Holdorf M; Liang TJ
    Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2306390120. PubMed ID: 38015841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replication.
    Zhang J; Zhang Y; Khanal S; Cao D; Zhao J; Dang X; Nguyen LNT; Schank M; Wu XY; Jiang Y; Ning S; Wang L; El Gazzar M; Moorman JP; Guo H; Yao ZQ
    J Med Virol; 2023 Jul; 95(7):e28952. PubMed ID: 37455550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription.
    Yu X; Long Q; Shen S; Liu Z; Chandran J; Zhang J; Ding H; Zhang H; Cai D; Kim ES; Huang Y; Guo H
    Antiviral Res; 2023 Mar; 211():105552. PubMed ID: 36737008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis.
    Wing PA; Davenne T; Wettengel J; Lai AG; Zhuang X; Chakraborty A; D'Arienzo V; Kramer C; Ko C; Harris JM; Schreiner S; Higgs M; Roessler S; Parish JL; Protzer U; Balfe P; Rehwinkel J; McKeating JA
    Life Sci Alliance; 2019 Apr; 2(2):. PubMed ID: 30918010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus.
    Shen Z; Zhang S; Gao Z; Yu X; Wang J; Pan S; Kang N; Liu N; Xu H; Liu M; Yang Y; Deng Q; Liu J; Xie Y; Zhang J
    J Virol; 2024 Feb; 98(2):e0134523. PubMed ID: 38226815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes.
    Giraud G; Rodà M; Huchon P; Michelet M; Maadadi S; Jutzi D; Montserret R; Ruepp MD; Parent R; Combet C; Zoulim F; Testoni B
    Nucleic Acids Res; 2024 Mar; 52(5):2290-2305. PubMed ID: 38113270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology of hepatitis B virus infection.
    Seeger C; Mason WS
    Virology; 2015 May; 479-480():672-86. PubMed ID: 25759099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA.
    Seeger C; Sohn JA
    Mol Ther; 2016 Aug; 24(7):1258-66. PubMed ID: 27203444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of HBV Covalently Closed Circular DNA.
    Li X; Zhao J; Yuan Q; Xia N
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28587292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.